SUNLENCA

Product Overview

About SUNLENCA

SUNLENCA is a prescription medication containing the active ingredient Lenacapavir (Lenacapavir Sodium), a novel HIV-1 capsid inhibitor. It is used in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults with limited or no treatment options.

Key Benefits & Uses

• Treatment of HIV-1 infection in adults with limited or no treatment options.
• Combination therapy with other antiretroviral agents for effective HIV-1 suppression.
• Reduction of viral load and improvement of immune function in HIV-1 infected individuals.

Active Ingredient & Action

Lenacapavir (Lenacapavir Sodium) works by inhibiting the HIV-1 capsid protein, which is essential for viral replication. By binding to the capsid, Lenacapavir prevents the virus from releasing its genetic material into the host cell, thereby inhibiting viral replication and reducing the viral load in the body.

Important Notes

SUNLENCA is available only by prescription and should be used under the guidance of a healthcare professional. It is essential to follow the recommended dosing regimen and to report any adverse reactions or concerns to your healthcare provider. SUNLENCA may interact with other medications, so inform your healthcare provider about all medications you are taking before starting treatment.